NCT05417165View on ClinicalTrials.gov

Anti-pneumococcal Vaccine Strategy in Patients with Chronic Lymphocytic Leukemia

PHASE2RecruitingINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

September 29, 2023

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma
Interventions
BIOLOGICAL

Pneumococcal 20-valent Conjugate Vaccine

Given IM

BIOLOGICAL

Pneumococcal Polyvalent Vaccine

Given IM

Trial Locations (1)

43210

RECRUITING

Ohio State University Comprehensive Cancer Center, Columbus

All Listed Sponsors
lead

Seema Bhat

OTHER